Microvascular Cardiac Allograft Vasculopathy Trial
If you've had a heart transplant, sometimes the small blood vessels in the new heart can develop problems. This condition is called 'microvascular graft vasculopathy'. This research study, called mCAV, is trying to get a really good picture of this problem. We want to understand what causes it by looking at people's genes, the exact structure of their new heart, and how well it's working. We'll use different tests like special scans (like MRI and echocardiograms), look at cells, and study blood samples to find out more. The goal is to better understand this condition so we can eventually find better ways to help people who experience it after a heart transplant.
At a glance
What is this study about?
This study is looking into a specific problem that can sometimes affect people who have had a heart transplant. It's called 'microvascular graft vasculopathy' (or mCAV for short). In simple terms, it means there are issues with the very tiny blood vessels within the new heart. These tiny vessels are crucial for supplying the heart muscle with blood and oxygen, so problems here can affect how well the new heart works.
The main aim of this research is to fully understand mCAV. The researchers want to discover why it happens, what factors contribute to it, and how it affects the heart. They'll be looking at a lot of different things, including a person's genetic makeup, detailed images of the heart's structure, and how effectively the heart is pumping blood. They will use a range of advanced medical tests and techniques to gather this information.
Why does this matter? By gaining a much clearer and more detailed understanding of mCAV, doctors hope to be able to identify people at risk earlier, and eventually develop better ways to prevent, diagnose, and treat this condition. This could lead to better long-term health outcomes and an improved quality of life for heart transplant recipients.
Key takeaways
- The study explores why small blood vessels in transplanted hearts sometimes develop issues.
- It aims to understand this condition using various medical tests and scans.
- No new medications are involved in this research.
- Your normal heart care will continue as usual.
- Participation is voluntary, and you can withdraw at any time.
- Findings could help improve care for future heart transplant patients.
Who may be eligible?
To take part in this study, you need to be an adult who has had a heart transplant and is well enough to give your clear agreement to participate. You should also be able to do some light exercise, like cycling or walking up two flights of stairs at a normal pace without feeling too out of breath or unwell. This is because some of the tests might involve gentle physical activity.
There are some reasons why you might not be able to join. For example, if you are pregnant or breastfeeding, or if you have certain serious health conditions like uncontrolled diabetes, advanced kidney disease needing dialysis, or cancer, you wouldn't be able to take part as these conditions could affect the study results. People with certain serious heart problems that would make exercise testing unsafe, or those who have difficulty understanding the study information, also wouldn't be able to participate. The research team will carefully check all of these points with you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Have I had a heart transplant?
- Am I able to understand the study and give my consent?
- Can I do mild exercise, like walking up two flights of stairs?
- Am I NOT currently pregnant or breastfeeding?
- Do I NOT have serious uncontrolled health conditions like advanced kidney disease or cancer?
What does participation involve?
The exact number of visits will depend on the specific tests you undergo, but generally, your participation would involve a few trips to the hospital or clinic. These visits would include various assessments such as special heart scans (like an echocardiogram and an MRI scan), and possibly a special test to measure how easily blood flows through the tiny vessels in your heart. You might also have blood samples taken to look at your genes.
The study also includes a test called a 'stress test', which involves some gentle exercise, usually on a stationary bike, while your heart is monitored. This helps doctors see how your heart works under mild exertion. There are no study medications involved here, and you will continue with your usual prescribed medications. The total duration of your participation would be explained fully by the study team, but it's typically over a period to gather all necessary information.
Potential risks and benefits
Locations (1)
- DHZC Deutsches Herzzentrum der CharitéVerified postcodeBerlin, Germany· Recruiting
Common questions
What is 'microvascular graft vasculopathy'?
It's a condition where the very small blood vessels inside a transplanted heart develop problems, which can affect how well the heart works.
Will I have to take any new medicines in this study?
No, this study does not involve taking any new medications. You will continue with your regular medicines as prescribed by your doctor.
What kind of tests will I have?
You might have heart scans (like MRI and ultrasound), blood tests, and a gentle exercise test to see how your heart works.
How long will my participation last?
The study team will explain the exact duration, but it typically involves several visits to gather all the necessary information over a period of time.
Can I leave the study if I change my mind?
Yes, you can withdraw from the study at any time, for any reason, and it will not affect your ongoing medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.